Pre-existing CD4 T cell help boosts antibody responses but has limited impact on germinal center, antigen-specific B cell frequencies after influenza infection

Front Immunol. 2023 Aug 30:14:1243164. doi: 10.3389/fimmu.2023.1243164. eCollection 2023.

Abstract

The influenza virus is a persistent burden on global health, with seasonal vaccines providing incomplete protection. CD4+ T cells help shape B cell and antibody responses; however, the selectivity of help and the effect on various antigen-specific B cell populations have not been fully elucidated. Here, we studied the specificity, selectivity, and influence of nucleoprotein (NP) CD4+ T cells on the magnitude and quality of hemagglutinin (HA) and NP-specific B cells and antibody responses. We identified immunodominant peptides and showed that peptide immunization was sufficient to induce CD4+ cells with Th1 and Tfh phenotypes. Surprisingly, while preexisting CD4+ T cells enhanced the influx of total germinal center (GC) B cells in the mediastinal lymph node after infection, this was not reflected by an increase in the frequency of antigen-specific cells within the GC. Furthermore, we demonstrated that NP-specific help was able to accelerate the kinetics and magnitude of the Ab response for NP but not for HA. Overall, our results showed that pre-existing CD4+ T cells provide strong cognate help during immunization or infection to enhance Ab production but not antigen-specific GC or memory B cells.

Keywords: B cells; CD4+ T cells; antibodies; germinal center; influenza.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Formation
  • B-Lymphocytes
  • CD4-Positive T-Lymphocytes
  • Germinal Center
  • Humans
  • Influenza Vaccines*
  • Influenza, Human*
  • Nucleoproteins

Substances

  • Influenza Vaccines
  • Nucleoproteins

Grants and funding

DA is supported by the European Research Council (B-DOMINANCE, grant no. 850638), the Knut and Alice Wallenberg Fellow Program (grant no. 2021.0033), the Swedish Research Council (grant no. 2017-01439, 2021-01164 and 2021-01165), the Jeanssons Foundation (grant nos. JS2018-0011 and JS2019-0038), and the Institute of Biomedicine at the University of Gothenburg.